Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Does ponatinib cross the blood-brain barrier?

British journal of haematology - 1 Nov 2017

Abid Muhammad B, De Mel Sanjay

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Kinase Inhibitors
Share to Pyridazines
Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood-Brain Barrier

Share to Fusion Proteins, bcr-abl

Share to Imidazoles

Share to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Source

Identifiers

PMID: 27352067
DOI: 10.1111/bjh.14222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Does ponatinib cross the blood-brain barrier?PMID 27352067Read ↗

A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood–brain Barrier in the Treatment of Patients With Philadelphia Chromosome–positive Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Effects of ABCB1 polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome-positive acute lymphoblastic leukaemia patients.Semantic proximity Read ↗

Effects of ABCB1 polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome-positive acute lymphoblastic leukaemia patientsSemantic proximity Read ↗

Where exactly does ponatinib fit in chronic myelogenous leukemia?Semantic proximity Read ↗

[Pharmacological and clinical profile of afatinib (Giotrif®)].Semantic proximity Read ↗

Management of ponatinib dosing in chronic myeloid leukemia patients.Semantic proximity Read ↗

DasatinibSemantic proximity Read ↗

P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?Semantic proximity Read ↗

P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib.Semantic proximity Read ↗

Ponatinib reduces viability, migration, and functionality of human endothelial cells.Semantic proximity Read ↗

In Silico Methods to Assess CNS Penetration of Small MoleculesSemantic proximity Read ↗

Importance of P-glycoprotein at blood–tissue barriersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.